Vancouver, Canada – November 16, 2017: The Centre for Drug Research and Development (CDRD), Canada’s national drug development and commercialization engine, is pleased to announce the appointment of Dr. Rachael Ritchie as Vice President, Strategy & Partnerships effective December 1, 2017.
Dr. Ritchie brings to CDRD a background that spans the University of British Columbia, Oxford and Harvard, and over 20 years of experience in life sciences R&D as a researcher, policy analyst, strategist, and leader. She has held multiple positions with the OECD in Paris, and Genome British Columbia in Vancouver including Director of International Partnerships and Director of Business Development.
As a developer and manager of large-scale, multi-partner, strategic partnerships, and interdisciplinary teams and projects, Dr. Ritchie will be responsible for the development and execution of CDRD’s corporate strategy, external R&D alliances, strategic scientific guidance for CDRD’s project portfolio, and will assume management responsibility for CDRD’s project search function.
CDRD Chair, Mr. Don Avison commented, “On behalf of the CDRD Board of Directors, I am pleased to welcome Dr. Ritchie. We are delighted to bring someone of Rachael’s broad background to the organization, and know she is going to be a tremendous asset in helping drive CDRD to its next level of success as a global bridge translating discoveries into innovative therapeutic products and improved health outcomes.”
Mr. Gordon C. McCauley, President and CEO of CDRD added, “Obviously, this role is a critical one in executing on both the project portfolio and partnership plans within CDRD’s strategy, and in ultimately realizing our vision of Canadian life sciences leading the world. Rachael will make a tremendous addition to the CDRD leadership team as we build on our partnerships across the country and around the world to identify and advance promising discoveries and transform them into validated investments.”
– 30 –
About The Centre for Drug Research and Development
(CDRD) CDRD is Canada’s national drug development and commercialization centre working in partnership with academia, industry, government and foundations. CDRD provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector — and ultimately into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR). www.cdrd.ca
For additional information, please contact: